Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS.

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Walter, Ingrid; Wolfesberger, Birgitt; Miller, Ingrid; Steinborn, Ralf; Burger, Stefanie Martina

Schlagwörter

Antineoplastic Agents/pharmacology*; Bone Neoplasms; Cell Line, Tumor; Down-Regulation; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic/drug effects; Humans; Niacinamide/analogs & derivatives*; Niacinamide/pharmacology; Oligonucleotide Array Sequence Analysis; Oncogene Proteins v-fos/genetics; Oncogene Proteins v-fos/metabolism*; Osteosarcoma; Phenylurea Compounds/pharmacology*; Receptors, CXCR4/genetics; Receptors, CXCR4/metabolism*; S100 Proteins/genetics; S100 Proteins/metabolism*; Transcriptome/drug effects;

ISSN/eISSN

1021-335X -

WoS ID

WOS:000332693700017